If you are interested in our services or solutions, please do not hesitate to contact us. We will get back to you as soon as possible.
Contact NowLiquid-liquid phase separation (LLPS) is a central player in the assembly of membrane-free compartments for biomolecular condensates. Various proteins, RNA and other biomolecules undergo LLPS and exhibit a variety of cellular functions. Researchers need to carefully design experiments to manipulate the phase separation of proteins without altering other functions or properties of biomolecular condensates. Guided by sequence analysis, mutations can be introduced into proteins to alter their phase separation properties. However, mutations of phase-separated proteins may not be as straightforward as for structural proteins. For example, altering the phase behavior of low complexity proteins. Developments in genetic engineering have played a very important role in the field of studying LLPS-controlled protein processes.
Fig. 1. A model of Tet1-mediated chromocenter clustering in DNA hypomethylated cells. (Hagihara Y, et al., 2021)
In addition to providing reliable experimental tools to assay LLPS in vitro, our experts are dedicated to extracting information about functional phase separation from the large number of natural sequence variants available in the post-genomic era, aiming to develop innovative tools to read this information and identify the key features and selection pressures behind phase separation in vivo. Here, CD BioSciences offers knockout and gene silencing methods to analyze LLPS-controlled protein processes in vivo.
These approaches have the advantage of allowing the analysis of each protein in a biomolecular condensed object to separate proteins that affect the formation of membraneless organelles (MLOs) from those that do not affect MLO biogenesis. The main strategies are as follows:
Both proteins and RNAs can be used as partners. We offer cutting-edge genetic engineering strategies to analyze LLPS-controlled protein processes in vivo. In addition, we attempt to develop RNA silencing assays to study the role of RNA. If you have any special requirements for our services, please feel free to contact us. We are looking forward to working together with your attractive projects.
Reference
CD BioSciences is a company conducting biomolecular condensates targeted innovative drugs. We integrate the latest advances in physics, chemistry, biology, and machine learning to address some of the most fundamental challenges in health and disease today.
Address:
Tel:
Email: